Poolbeg Pharma PLC Cash Flow-to-Debt Ratio
Poolbeg Pharma PLC cash flow-to-debt ratio. Poolbeg Pharma PLC (POLB) has a Cash Flow-to-Debt Ratio of -1.61x as of December 2025, meaning its operating cash flow of GBX-2.16 Million could theoretically repay -2% of its total liabilities (GBX1.34 Million) in one year. See POLB free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Poolbeg Pharma PLC (2021–2025)
Cash flow-to-debt ratio of Poolbeg Pharma PLC from 2021 to 2025. Historical debt coverage capacity for Poolbeg Pharma PLC across 5 annual periods. See Poolbeg Pharma PLC balance sheet independence to measure how much of total assets are equity-financed.
Poolbeg Pharma PLC Cash Flow-to-Debt Ratio by Year (2021–2025)
Poolbeg Pharma PLC cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for Poolbeg Pharma PLC. For the full cash flow conversion analysis, see POLB cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.36x | GBX-4.51 Million | GBX1.34 Million | ▲ +29.5% |
| 2024 | -4.77x | GBX-4.65 Million | GBX974.00K | ▼ -7.4% |
| 2023 | -4.44x | GBX-4.38 Million | GBX986.00K | ▲ +1.7% |
| 2022 | -4.52x | GBX-4.37 Million | GBX966.00K | ▲ +7.7% |
| 2021 | -4.90x | GBX-2.15 Million | GBX438.00K | — |